Caricamento...
Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis
The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal ( GI ) symptoms. We asked whether the analysis of plasma could provide insight into gut barrier dysf...
Salvato in:
| Pubblicato in: | bioRxiv |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cold Spring Harbor Laboratory
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043449/ https://ncbi.nlm.nih.gov/pubmed/33851159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.06.438634 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|